Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma

scholarly article by Annemieke W J Opstal-van Winden et al published 7 March 2019 in Blood

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2018-07-862607
P932PMC publication ID6405334
P698PubMed publication ID30573632

P50authorJulian PetoQ6307461
Hoda Anton-CulverQ28052887
Angela CoxQ28484012
Anthony SwerdlowQ60492223
Paul D P PharoahQ61822938
Fergus J. CouchQ63018779
Christopher A. HaimanQ73606228
Annegien BroeksQ73632596
Maartje J. HooningQ74014444
Elinor J. SawyerQ74173254
Nick OrrQ78318000
Les RobisonQ91435233
Peter DevileeQ37361664
Joe DennisQ56875626
Douglas F. EastonQ59812154
P2093author name stringLouise C Strong
Michael Hauptmann
Hugoline G de Haan
Rosie Cooke
Smita Bhatia
Flora E van Leeuwen
Marjanka K Schmidt
Marie L De Bruin
Berthe M P Aleman
Nicola S Russell
Frederieke H van der Baan
Anna M van Eggermond
Augustinus D G Krol
Cécile P M Janus
Annemieke W J Opstal-van Winden
P2860cites workVariants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaQ24632704
A global reference for human genetic variationQ25909434
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthoodQ28143725
Ageing or cancer: a review on the role of caretakers and gatekeepersQ28244257
Common polygenic variation contributes to risk of schizophrenia and bipolar disorderQ28250609
Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologistsQ28387859
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Q28943455
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.Q31926021
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersQ33614244
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's diseaseQ33773312
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologistsQ33813463
Breast cancer after chest radiation therapy for childhood cancerQ33910979
Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologistsQ34070675
Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapyQ34250220
Power and predictive accuracy of polygenic risk scores.Q34337027
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based studyQ34477813
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupQ34639851
Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studiesQ72278250
High risk of breast carcinoma after irradiation of young women with Hodgkin's diseaseQ73155448
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsQ74675998
Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor StudyQ80879443
p53-Dependent induction of PVT1 and miR-1204.Q35709920
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New YorkQ36615332
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factorsQ36924721
Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologistsQ36973531
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer familiesQ37131918
Radiation dose and breast cancer risk in the childhood cancer survivor studyQ37324982
Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologistsQ37700040
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.Q38410659
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphomaQ38471731
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersQ38717239
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancerQ39844032
The identification of microRNAs in a genomically unstable region of human chromosome 8q24.Q40006769
Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone ExposureQ40049393
Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutationsQ42628531
Association analysis identifies 65 new breast cancer risk loci.Q45979098
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerQ46103372
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumQ47190168
Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body IrradiationQ47225128
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort StudyQ47576468
Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood CancerQ47601903
High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study GroupQ47644209
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's diseaseQ47788586
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.Q51621180
Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.Q53241145
TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.Q53372775
Breast cancer after treatment of Hodgkin's disease.Q53483025
Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3Q57202062
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologistsQ57250667
Polymorphisms in Apoptosis- and Proliferation-Related Genes, Ionizing Radiation Exposure, and Risk of Breast Cancer among U.S. Radiologic TechnologistsQ57250681
FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphomaQ57319538
Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's LymphomaQ58410899
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
hematologyQ103824
Hodgkin lymphomaQ209369
P304page(s)1130-1139
P577publication date2019-03-07
P1433published inBloodQ885070
P1476titleGenetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma
P478volume133

Reverse relations

cites work (P2860)
Q90529207Current and coming challenges in the management of the survivorship population
Q90134014Individual response of humans to ionising radiation: governing factors and importance for radiological protection

Search more.